 | • レポートコード：MRC2-11QY08363 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は腫瘍学/がん治療薬のグローバル市場について調査・分析したレポートです。種類別（代謝拮抗剤、アルカロイド薬、ホルモン、標的薬、白金系薬、その他）市場規模、用途別（血液がん、乳がん、消化器がん、前立腺がん、呼吸器・肺がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別腫瘍学/がん治療薬の競争状況、市場シェア ・世界の腫瘍学/がん治療薬市場：種類別市場規模 2015年-2020年（代謝拮抗剤、アルカロイド薬、ホルモン、標的薬、白金系薬、その他） ・世界の腫瘍学/がん治療薬市場：種類別市場規模予測 2021年-2026年（代謝拮抗剤、アルカロイド薬、ホルモン、標的薬、白金系薬、その他） ・世界の腫瘍学/がん治療薬市場：用途別市場規模 2015年-2020年（血液がん、乳がん、消化器がん、前立腺がん、呼吸器・肺がん、その他） ・世界の腫瘍学/がん治療薬市場：用途別市場規模予測 2021年-2026年（血液がん、乳がん、消化器がん、前立腺がん、呼吸器・肺がん、その他） ・北米の腫瘍学/がん治療薬市場分析：米国、カナダ ・ヨーロッパの腫瘍学/がん治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの腫瘍学/がん治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の腫瘍学/がん治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの腫瘍学/がん治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche、HENGRUI、AstraZeneca、QILU、Sanofi、HANSOH、LUYE、Novartis、GuiZhou YiBai、Lunan、Eli Lilly and Company ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
Oncology Drugs is widely used For Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory/Lung Cancer and Other Cancer Treatment. The most proportion of Oncology Drugs used for Blood Cancer and the proportion in 2017 is 22.74%.
Market Analysis and Insights: Global Oncology/Cancer Drugs Market
The global Oncology/Cancer Drugs market size is projected to reach US$ 96510 million by 2026, from US$ 92220 million in 2020, at a CAGR of 4.3%% during 2021-2026.
Global Oncology/Cancer Drugs Scope and Market Size
Oncology/Cancer Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oncology/Cancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Oncology/Cancer Drugs market is segmented into
Antimetabolite
Alkaloid drugs
Hormone
Targeted drug
Platinum-based drugs
Other
Segment by Application, the Oncology/Cancer Drugs market is segmented into
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other
Regional and Country-level Analysis
The Oncology/Cancer Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Oncology/Cancer Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oncology/Cancer Drugs Market Share Analysis
Oncology/Cancer Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oncology/Cancer Drugs business, the date to enter into the Oncology/Cancer Drugs market, Oncology/Cancer Drugs product introduction, recent developments, etc.
The major vendors covered:
Roche
HENGRUI
AstraZeneca
QILU
Sanofi
HANSOH
LUYE
Novartis
GuiZhou YiBai
Lunan
Eli Lilly and Company
1 Study Coverage
1.1 Oncology/Cancer Drugs Product Introduction
1.2 Market Segments
1.3 Key Oncology/Cancer Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Oncology/Cancer Drugs Market Size Growth Rate by Type
1.4.2 Antimetabolite
1.4.3 Alkaloid drugs
1.4.4 Hormone
1.4.5 Targeted drug
1.4.6 Platinum-based drugs
1.4.7 Other
1.5 Market by Application
1.5.1 Global Oncology/Cancer Drugs Market Size Growth Rate by Application
1.5.2 Blood Cancer
1.5.3 Breast Cancer
1.5.4 Gastrointestinal Cancer
1.5.5 Prostate Cancer
1.5.6 Respiratory/Lung Cancer
1.5.7 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Oncology/Cancer Drugs Market Size, Estimates and Forecasts
2.1.1 Global Oncology/Cancer Drugs Revenue 2015-2026
2.1.2 Global Oncology/Cancer Drugs Sales 2015-2026
2.2 Global Oncology/Cancer Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Oncology/Cancer Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Oncology/Cancer Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Oncology/Cancer Drugs Competitor Landscape by Players
3.1 Oncology/Cancer Drugs Sales by Manufacturers
3.1.1 Oncology/Cancer Drugs Sales by Manufacturers (2015-2020)
3.1.2 Oncology/Cancer Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Oncology/Cancer Drugs Revenue by Manufacturers
3.2.1 Oncology/Cancer Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Oncology/Cancer Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Oncology/Cancer Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Oncology/Cancer Drugs Revenue in 2019
3.2.5 Global Oncology/Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Oncology/Cancer Drugs Price by Manufacturers
3.4 Oncology/Cancer Drugs Manufacturing Base Distribution, Product Types
3.4.1 Oncology/Cancer Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oncology/Cancer Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Oncology/Cancer Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Oncology/Cancer Drugs Market Size by Type (2015-2020)
4.1.1 Global Oncology/Cancer Drugs Sales by Type (2015-2020)
4.1.2 Global Oncology/Cancer Drugs Revenue by Type (2015-2020)
4.1.3 Oncology/Cancer Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Oncology/Cancer Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Oncology/Cancer Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Oncology/Cancer Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Oncology/Cancer Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Oncology/Cancer Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Oncology/Cancer Drugs Market Size by Application (2015-2020)
5.1.1 Global Oncology/Cancer Drugs Sales by Application (2015-2020)
5.1.2 Global Oncology/Cancer Drugs Revenue by Application (2015-2020)
5.1.3 Oncology/Cancer Drugs Price by Application (2015-2020)
5.2 Oncology/Cancer Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Oncology/Cancer Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Oncology/Cancer Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Oncology/Cancer Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Oncology/Cancer Drugs by Country
6.1.1 North America Oncology/Cancer Drugs Sales by Country
6.1.2 North America Oncology/Cancer Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Oncology/Cancer Drugs Market Facts & Figures by Type
6.3 North America Oncology/Cancer Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Oncology/Cancer Drugs by Country
7.1.1 Europe Oncology/Cancer Drugs Sales by Country
7.1.2 Europe Oncology/Cancer Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oncology/Cancer Drugs Market Facts & Figures by Type
7.3 Europe Oncology/Cancer Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Oncology/Cancer Drugs by Region
8.1.1 Asia Pacific Oncology/Cancer Drugs Sales by Region
8.1.2 Asia Pacific Oncology/Cancer Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Oncology/Cancer Drugs Market Facts & Figures by Type
8.3 Asia Pacific Oncology/Cancer Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Oncology/Cancer Drugs by Country
9.1.1 Latin America Oncology/Cancer Drugs Sales by Country
9.1.2 Latin America Oncology/Cancer Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Oncology/Cancer Drugs Market Facts & Figures by Type
9.3 Central & South America Oncology/Cancer Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Oncology/Cancer Drugs by Country
10.1.1 Middle East and Africa Oncology/Cancer Drugs Sales by Country
10.1.2 Middle East and Africa Oncology/Cancer Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Oncology/Cancer Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Oncology/Cancer Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Oncology/Cancer Drugs Products Offered
11.1.5 Roche Related Developments
11.2 HENGRUI
11.2.1 HENGRUI Corporation Information
11.2.2 HENGRUI Description and Business Overview
11.2.3 HENGRUI Sales, Revenue and Gross Margin (2015-2020)
11.2.4 HENGRUI Oncology/Cancer Drugs Products Offered
11.2.5 HENGRUI Related Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Corporation Information
11.3.2 AstraZeneca Description and Business Overview
11.3.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.3.4 AstraZeneca Oncology/Cancer Drugs Products Offered
11.3.5 AstraZeneca Related Developments
11.4 QILU
11.4.1 QILU Corporation Information
11.4.2 QILU Description and Business Overview
11.4.3 QILU Sales, Revenue and Gross Margin (2015-2020)
11.4.4 QILU Oncology/Cancer Drugs Products Offered
11.4.5 QILU Related Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Description and Business Overview
11.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sanofi Oncology/Cancer Drugs Products Offered
11.5.5 Sanofi Related Developments
11.6 HANSOH
11.6.1 HANSOH Corporation Information
11.6.2 HANSOH Description and Business Overview
11.6.3 HANSOH Sales, Revenue and Gross Margin (2015-2020)
11.6.4 HANSOH Oncology/Cancer Drugs Products Offered
11.6.5 HANSOH Related Developments
11.7 LUYE
11.7.1 LUYE Corporation Information
11.7.2 LUYE Description and Business Overview
11.7.3 LUYE Sales, Revenue and Gross Margin (2015-2020)
11.7.4 LUYE Oncology/Cancer Drugs Products Offered
11.7.5 LUYE Related Developments
11.8 Novartis
11.8.1 Novartis Corporation Information
11.8.2 Novartis Description and Business Overview
11.8.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Novartis Oncology/Cancer Drugs Products Offered
11.8.5 Novartis Related Developments
11.9 GuiZhou YiBai
11.9.1 GuiZhou YiBai Corporation Information
11.9.2 GuiZhou YiBai Description and Business Overview
11.9.3 GuiZhou YiBai Sales, Revenue and Gross Margin (2015-2020)
11.9.4 GuiZhou YiBai Oncology/Cancer Drugs Products Offered
11.9.5 GuiZhou YiBai Related Developments
11.10 Lunan
11.10.1 Lunan Corporation Information
11.10.2 Lunan Description and Business Overview
11.10.3 Lunan Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Lunan Oncology/Cancer Drugs Products Offered
11.10.5 Lunan Related Developments
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Oncology/Cancer Drugs Products Offered
11.1.5 Roche Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Oncology/Cancer Drugs Market Estimates and Projections by Region
12.1.1 Global Oncology/Cancer Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Oncology/Cancer Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Oncology/Cancer Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Oncology/Cancer Drugs Sales Forecast (2021-2026)
12.2.2 North America: Oncology/Cancer Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Oncology/Cancer Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Oncology/Cancer Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Oncology/Cancer Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Oncology/Cancer Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Oncology/Cancer Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Oncology/Cancer Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Oncology/Cancer Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Oncology/Cancer Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Oncology/Cancer Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Oncology/Cancer Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Oncology/Cancer Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Oncology/Cancer Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Oncology/Cancer Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Oncology/Cancer Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Oncology/Cancer Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Oncology/Cancer Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Oncology/Cancer Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Oncology/Cancer Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oncology/Cancer Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Oncology/Cancer Drugs Market Segments
Table 2. Ranking of Global Top Oncology/Cancer Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Oncology/Cancer Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Antimetabolite
Table 5. Major Manufacturers of Alkaloid drugs
Table 6. Major Manufacturers of Hormone
Table 7. Major Manufacturers of Targeted drug
Table 8. Major Manufacturers of Platinum-based drugs
Table 9. Major Manufacturers of Other
Table 10. Global Oncology/Cancer Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 11. Global Oncology/Cancer Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 12. Global Oncology/Cancer Drugs Sales by Regions 2015-2020 (K MT)
Table 13. Global Oncology/Cancer Drugs Sales Market Share by Regions (2015-2020)
Table 14. Global Oncology/Cancer Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Oncology/Cancer Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 16. Global Oncology/Cancer Drugs Sales Share by Manufacturers (2015-2020)
Table 17. Global Oncology/Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Oncology/Cancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology/Cancer Drugs as of 2019)
Table 19. Oncology/Cancer Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Oncology/Cancer Drugs Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Oncology/Cancer Drugs Price (2015-2020) (USD/MT)
Table 22. Oncology/Cancer Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Oncology/Cancer Drugs Product Type
Table 24. Date of International Manufacturers Enter into Oncology/Cancer Drugs Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Oncology/Cancer Drugs Sales by Type (2015-2020) (K MT)
Table 27. Global Oncology/Cancer Drugs Sales Share by Type (2015-2020)
Table 28. Global Oncology/Cancer Drugs Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Oncology/Cancer Drugs Revenue Share by Type (2015-2020)
Table 30. Oncology/Cancer Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 31. Global Oncology/Cancer Drugs Sales by Application (2015-2020) (K MT)
Table 32. Global Oncology/Cancer Drugs Sales Share by Application (2015-2020)
Table 33. North America Oncology/Cancer Drugs Sales by Country (2015-2020) (K MT)
Table 34. North America Oncology/Cancer Drugs Sales Market Share by Country (2015-2020)
Table 35. North America Oncology/Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Oncology/Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 37. North America Oncology/Cancer Drugs Sales by Type (2015-2020) (K MT)
Table 38. North America Oncology/Cancer Drugs Sales Market Share by Type (2015-2020)
Table 39. North America Oncology/Cancer Drugs Sales by Application (2015-2020) (K MT)
Table 40. North America Oncology/Cancer Drugs Sales Market Share by Application (2015-2020)
Table 41. Europe Oncology/Cancer Drugs Sales by Country (2015-2020) (K MT)
Table 42. Europe Oncology/Cancer Drugs Sales Market Share by Country (2015-2020)
Table 43. Europe Oncology/Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Oncology/Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 45. Europe Oncology/Cancer Drugs Sales by Type (2015-2020) (K MT)
Table 46. Europe Oncology/Cancer Drugs Sales Market Share by Type (2015-2020)
Table 47. Europe Oncology/Cancer Drugs Sales by Application (2015-2020) (K MT)
Table 48. Europe Oncology/Cancer Drugs Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Oncology/Cancer Drugs Sales by Region (2015-2020) (K MT)
Table 50. Asia Pacific Oncology/Cancer Drugs Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Oncology/Cancer Drugs Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Oncology/Cancer Drugs Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Oncology/Cancer Drugs Sales by Type (2015-2020) (K MT)
Table 54. Asia Pacific Oncology/Cancer Drugs Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Oncology/Cancer Drugs Sales by Application (2015-2020) (K MT)
Table 56. Asia Pacific Oncology/Cancer Drugs Sales Market Share by Application (2015-2020)
Table 57. Latin America Oncology/Cancer Drugs Sales by Country (2015-2020) (K MT)
Table 58. Latin America Oncology/Cancer Drugs Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Oncology/Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Oncology/Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 61. Latin America Oncology/Cancer Drugs Sales by Type (2015-2020) (K MT)
Table 62. Latin America Oncology/Cancer Drugs Sales Market Share by Type (2015-2020)
Table 63. Latin America Oncology/Cancer Drugs Sales by Application (2015-2020) (K MT)
Table 64. Latin America Oncology/Cancer Drugs Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Oncology/Cancer Drugs Sales by Country (2015-2020) (K MT)
Table 66. Middle East and Africa Oncology/Cancer Drugs Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Oncology/Cancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Oncology/Cancer Drugs Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Oncology/Cancer Drugs Sales by Type (2015-2020) (K MT)
Table 70. Middle East and Africa Oncology/Cancer Drugs Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Oncology/Cancer Drugs Sales by Application (2015-2020) (K MT)
Table 72. Middle East and Africa Oncology/Cancer Drugs Sales Market Share by Application (2015-2020)
Table 73. Roche Corporation Information
Table 74. Roche Description and Major Businesses
Table 75. Roche Oncology/Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 76. Roche Product
Table 77. Roche Recent Development
Table 78. HENGRUI Corporation Information
Table 79. HENGRUI Description and Major Businesses
Table 80. HENGRUI Oncology/Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. HENGRUI Product
Table 82. HENGRUI Recent Development
Table 83. AstraZeneca Corporation Information
Table 84. AstraZeneca Description and Major Businesses
Table 85. AstraZeneca Oncology/Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. AstraZeneca Product
Table 87. AstraZeneca Recent Development
Table 88. QILU Corporation Information
Table 89. QILU Description and Major Businesses
Table 90. QILU Oncology/Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. QILU Product
Table 92. QILU Recent Development
Table 93. Sanofi Corporation Information
Table 94. Sanofi Description and Major Businesses
Table 95. Sanofi Oncology/Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. Sanofi Product
Table 97. Sanofi Recent Development
Table 98. HANSOH Corporation Information
Table 99. HANSOH Description and Major Businesses
Table 100. HANSOH Oncology/Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 101. HANSOH Product
Table 102. HANSOH Recent Development
Table 103. LUYE Corporation Information
Table 104. LUYE Description and Major Businesses
Table 105. LUYE Oncology/Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 106. LUYE Product
Table 107. LUYE Recent Development
Table 108. Novartis Corporation Information
Table 109. Novartis Description and Major Businesses
Table 110. Novartis Oncology/Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 111. Novartis Product
Table 112. Novartis Recent Development
Table 113. GuiZhou YiBai Corporation Information
Table 114. GuiZhou YiBai Description and Major Businesses
Table 115. GuiZhou YiBai Oncology/Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 116. GuiZhou YiBai Product
Table 117. GuiZhou YiBai Recent Development
Table 118. Lunan Corporation Information
Table 119. Lunan Description and Major Businesses
Table 120. Lunan Oncology/Cancer Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 121. Lunan Product
Table 122. Lunan Recent Development
Table 123. Eli Lilly and Company Corporation Information
Table 124. Eli Lilly and Company Description and Major Businesses
Table 125. Eli Lilly and Company Oncology/Cancer Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 126. Eli Lilly and Company Product
Table 127. Eli Lilly and Company Recent Development
Table 128. Global Oncology/Cancer Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 129. Global Oncology/Cancer Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 130. Global Oncology/Cancer Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 131. Global Oncology/Cancer Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 132. North America: Oncology/Cancer Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 133. North America: Oncology/Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Europe: Oncology/Cancer Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 135. Europe: Oncology/Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Asia Pacific: Oncology/Cancer Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 137. Asia Pacific: Oncology/Cancer Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 138. Latin America: Oncology/Cancer Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 139. Latin America: Oncology/Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Middle East and Africa: Oncology/Cancer Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 141. Middle East and Africa: Oncology/Cancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 143. Key Challenges
Table 144. Market Risks
Table 145. Main Points Interviewed from Key Oncology/Cancer Drugs Players
Table 146. Oncology/Cancer Drugs Customers List
Table 147. Oncology/Cancer Drugs Distributors List
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Oncology/Cancer Drugs Product Picture
Figure 2. Global Oncology/Cancer Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Antimetabolite Product Picture
Figure 4. Alkaloid drugs Product Picture
Figure 5. Hormone Product Picture
Figure 6. Targeted drug Product Picture
Figure 7. Platinum-based drugs Product Picture
Figure 8. Other Product Picture
Figure 9. Global Oncology/Cancer Drugs Sales Market Share by Application in 2020 & 2026
Figure 10. Blood Cancer
Figure 11. Breast Cancer
Figure 12. Gastrointestinal Cancer
Figure 13. Prostate Cancer
Figure 14. Respiratory/Lung Cancer
Figure 15. Other
Figure 16. Oncology/Cancer Drugs Report Years Considered
Figure 17. Global Oncology/Cancer Drugs Market Size 2015-2026 (US$ Million)
Figure 18. Global Oncology/Cancer Drugs Sales 2015-2026 (K MT)
Figure 19. Global Oncology/Cancer Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 20. Global Oncology/Cancer Drugs Sales Market Share by Region (2015-2020)
Figure 21. Global Oncology/Cancer Drugs Sales Market Share by Region in 2019
Figure 22. Global Oncology/Cancer Drugs Revenue Market Share by Region (2015-2020)
Figure 23. Global Oncology/Cancer Drugs Revenue Market Share by Region in 2019
Figure 24. Global Oncology/Cancer Drugs Sales Share by Manufacturer in 2019
Figure 25. The Top 10 and 5 Players Market Share by Oncology/Cancer Drugs Revenue in 2019
Figure 26. Oncology/Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Oncology/Cancer Drugs Sales Market Share by Type (2015-2020)
Figure 28. Global Oncology/Cancer Drugs Sales Market Share by Type in 2019
Figure 29. Global Oncology/Cancer Drugs Revenue Market Share by Type (2015-2020)
Figure 30. Global Oncology/Cancer Drugs Revenue Market Share by Type in 2019
Figure 31. Global Oncology/Cancer Drugs Market Share by Price Range (2015-2020)
Figure 32. Global Oncology/Cancer Drugs Sales Market Share by Application (2015-2020)
Figure 33. Global Oncology/Cancer Drugs Sales Market Share by Application in 2019
Figure 34. Global Oncology/Cancer Drugs Revenue Market Share by Application (2015-2020)
Figure 35. Global Oncology/Cancer Drugs Revenue Market Share by Application in 2019
Figure 36. North America Oncology/Cancer Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 37. North America Oncology/Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America Oncology/Cancer Drugs Sales Market Share by Country in 2019
Figure 39. North America Oncology/Cancer Drugs Revenue Market Share by Country in 2019
Figure 40. U.S. Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 41. U.S. Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 43. Canada Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. North America Oncology/Cancer Drugs Market Share by Type in 2019
Figure 45. North America Oncology/Cancer Drugs Market Share by Application in 2019
Figure 46. Europe Oncology/Cancer Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 47. Europe Oncology/Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Oncology/Cancer Drugs Sales Market Share by Country in 2019
Figure 49. Europe Oncology/Cancer Drugs Revenue Market Share by Country in 2019
Figure 50. Germany Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 51. Germany Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 53. France Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 55. U.K. Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 57. Italy Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 59. Russia Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Europe Oncology/Cancer Drugs Market Share by Type in 2019
Figure 61. Europe Oncology/Cancer Drugs Market Share by Application in 2019
Figure 62. Asia Pacific Oncology/Cancer Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 63. Asia Pacific Oncology/Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 64. Asia Pacific Oncology/Cancer Drugs Sales Market Share by Region in 2019
Figure 65. Asia Pacific Oncology/Cancer Drugs Revenue Market Share by Region in 2019
Figure 66. China Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 67. China Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Japan Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 69. Japan Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. South Korea Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 71. South Korea Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. India Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 73. India Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Australia Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 75. Australia Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Taiwan Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 77. Taiwan Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Indonesia Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 79. Indonesia Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Thailand Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 81. Thailand Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Malaysia Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 83. Malaysia Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Philippines Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 85. Philippines Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Vietnam Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 87. Vietnam Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Asia Pacific Oncology/Cancer Drugs Market Share by Type in 2019
Figure 89. Asia Pacific Oncology/Cancer Drugs Market Share by Application in 2019
Figure 90. Latin America Oncology/Cancer Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 91. Latin America Oncology/Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America Oncology/Cancer Drugs Sales Market Share by Country in 2019
Figure 93. Latin America Oncology/Cancer Drugs Revenue Market Share by Country in 2019
Figure 94. Mexico Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 95. Mexico Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Brazil Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 97. Brazil Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Argentina Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 99. Argentina Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Latin America Oncology/Cancer Drugs Market Share by Type in 2019
Figure 101. Latin America Oncology/Cancer Drugs Market Share by Application in 2019
Figure 102. Middle East and Africa Oncology/Cancer Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 103. Middle East and Africa Oncology/Cancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 104. Middle East and Africa Oncology/Cancer Drugs Sales Market Share by Country in 2019
Figure 105. Middle East and Africa Oncology/Cancer Drugs Revenue Market Share by Country in 2019
Figure 106. Turkey Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 107. Turkey Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Saudi Arabia Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 109. Saudi Arabia Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. U.A.E Oncology/Cancer Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 111. U.A.E Oncology/Cancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 112. Middle East and Africa Oncology/Cancer Drugs Market Share by Type in 2019
Figure 113. Middle East and Africa Oncology/Cancer Drugs Market Share by Application in 2019
Figure 114. North America Oncology/Cancer Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. North America Oncology/Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe Oncology/Cancer Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Europe Oncology/Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific Oncology/Cancer Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Asia Pacific Oncology/Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America Oncology/Cancer Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 121. Latin America Oncology/Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa Oncology/Cancer Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 123. Middle East and Africa Oncology/Cancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed
精巣腫瘍治療薬の世界市場（～2026年） Market Analysis and Insights: Global Testicular Cancer Drugs Market The global Testicular Cancer Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Testicular Cancer Drugs Scope and Market Size Testicular Cancer Dru…- 頭頸部がん治療薬/治療の世界市場（～2026年） Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands. Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private…
- 腎臓/腎がん治療薬の世界市場（～2026年） Kidney/Renal Cancer Drugs are used to cure kidney cancers. The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking. Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors bo…
- 尿管がん治療薬の世界市場（～2026年） Market Analysis and Insights: Global Ureter Cancer Drugs Market The global Ureter Cancer Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ureter Cancer Drugs Scope and Market Size Ureter Cancer Drugs market is seg…
- 胃がん治療薬の世界市場（～2026年） Gastric cancer drugs are used to treat malignancies, or cancerous growths. The APAC region to account for the highest market share during the forecast period. Much of this region’s growth can be attributed to the increasing demand for better healthcare infrastructure, which results in its massive ma…